Company: CDT
Filing Date: 2025-02-06
Form Type: S-8
Source: 0001493152-25-005249
Chunk: 6

Company: CDT Equity Inc.
Filing Date: 2025-02-06
Form: S-8
Chunk 6
---
 Florida, on February 6, 2025.

| CONDUIT PHARMACEUTICALS INC. |                                |
| By:                          | /s/                            
 David Tapolczay                |
|                              | Name: David Tapolczay          |
|                              | Title: Chief Executive Officer |

<div align='center'>POWER OF ATTORNEY</div>

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints David Tapolczay and/or James Bligh, and each of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his substitutes or substitute, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the undersigned, thereunto duly authorized.

| Signature              
 /s/                    
 David Tapolczay        |     | Title                            
 Chief Executive Officer          
 and Director                     |     | Date             
 February 6, 2025 |
|:-----------------------|:----|:---------------------------------|:----|:-----------------|
| David Tapolczay        |     | -Principal Executive Officer     |     |                  |
| /s/                    
 James Bligh            |     | Interim Chief Financial          
 Officer and Director             |     | February 6, 2025 |
| James Bligh            |     | -Principal Financial Officer     
 and Principal Accounting Officer |     |                  |
| /s/                    
 Freda Lewis-Hall       |     | Director and Chairperson         
 of the Board of Directors        |     | February 6, 2025 |
| Freda Lewis-Hall       |     |